Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers report details of new studies and findings in the area of breast cancer
May 19th, 2005
Breast cancer data are the focus of recent research from the United States. Study 1: According to a study from the United States, "Cytochrome P450 1B1 (CYP1B1) and catechol-O-methyltransferase (COMT) are important estrogen-metabolizing enzymes and, thus, genetic polymorphisms of these enzymes may affect breast cancer risk." W.Q. Wen and colleagues, Vanderbilt University, conducted "a population-based case-control study ...to assess the association of breast cancer risk with CYP1B1 and COMT polymorphisms. A meta-analysis was done to summarize the findings from this and previous studies." They said, "Included in this study were...
Source: Women's Health Weekly (2005-05-19)
|
